‘Risk of European cancer epidemic in next 10 years’ if weaknesses not addressed

The study also finds Brexit will continue to negatively impact European cancer research unless European funders/research community and the UK government/research community find a way for continued collaboration.

Picture: Rui Vieira/PA Wire

An estimated one million cancer diagnoses were missed across Europe in the last two years, and a new report suggests the impact of Covid-19 could set back European cancer results by almost a decade.

Researchers say the pandemic has exposed weaknesses in cancer health systems and in the research landscape across the continent.